Skip to content

The combined application of Pronase and Simethicone during upper gastrointestinal endoscopy: a prospective, multicenter, large-sample-size, randomized, controlled, double-blind trail

The combined application of Pronase and Simethicone during upper gastrointestinal endoscopy: a prospective, multicenter, large-sample-size, randomized, controlled, double-blind trail

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010985
Enrollment
Unknown
Registered
2017-03-26
Start date
2015-02-25
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early cancer and precancerous lesions of upper gastrointestinal endoscopy

Interventions

groupA:20000u pronase and 1g water
groupB:80mg simethicone and 100ml water
groupC:20000u pronase, 80mg simethicone and 100ml water
groupD:100ml water

Sponsors

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40 to 69 years old male and female; 2. tested voluntarily, and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. complete pyloric obstruction; 2. active gastrointestinal bleeding; 3. history of upper gastrointestinal surgery; 4. severe heart, liver, and kidney dysfunction and could not accept painless endoscopy; 5. pregnant and lactating women; 6. participated in other clinical studies within a month; 7. psychosis and severe neurosis; 8. allergy to all the drugs used in the test.

Design outcomes

Primary

MeasureTime frame
influence on lesion detection rate by different premedication;cost and benefit of different premedication;

Secondary

MeasureTime frame
influence on mucosal visualization by different premedication;influence on examination time by different premedication;influence on flushing water volume by different premedication;Influence on visibility scores by different kinds of activities;

Countries

China

Contacts

Public ContactWang Guiqi

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

wangguiq@126.com+86 18101066642

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 7, 2026